Patterson D L, Wiemann M C, Lee T H, Byron W A
St. Vincent Hospital, Indianapolis.
Chest. 1993 Jul;104(1):315-7. doi: 10.1378/chest.104.1.315.
Carmustine is a chemotherapeutic agent frequently employed in the treatment of malignant brain tumors. The side effect of pulmonary fibrosis occurs in 20 to 30 percent of patients receiving this drug. Herein we report a case of presumed carmustine-induced pulmonary fibrosis occurring with an unusual lobar distribution.
卡莫司汀是一种常用于治疗恶性脑肿瘤的化疗药物。接受该药物治疗的患者中，有20%至30%会出现肺纤维化的副作用。在此，我们报告一例疑似卡莫司汀诱导的肺纤维化病例，其具有不寻常的叶分布。
